MGMT and neoplasm: We conjecture that this study identifies a class of predominantly rare tumour suppressors, such as CPEB3 and MGMT, that are more prone to be inactivated by homozygous deletions than point mutations, a proportion of which therefore may not be readily identifiable through mutation analysis given current sample sizes.